Astell units sterilise contaminated lab waste
Astell markets liquid waste treatment plants for Category 3 and 4 labs
Current legislation requires that all waste water from sinks, washrooms, sanitary installations and similar facilities within these designated areas have to be sterilised prior to discharge to sewer. The Astell units cover capacities from 100 to 5000 litres of liquid waste per day.
In the standard batch processing unit, liquid waste is collected in a stainless steel jacketed containment tank. When the radar level controller detects that the tank is full, the heat sterilisation sequence starts automatically.
Heating is by steam supplied either from the unit’s integral steam generator or from an external source. Once the sequence is complete, the sterilised effluent is discharged to sewer using compressed air.
Continuous processing units are provided with two tanks. The first tank is filled as in the batch operation, and commences sterilisation. Influent liquid waste is then diverted to the second tank. When the sterilisation sequence is complete, the tank remains idle until the second tank is full. In this way effluent collection is continuous so there is no delay to laboratory operations.
Each tank is fully contained and all connections are above liquid level eliminating dangerous and costly leaks. A vent filter ensures that no microbial contaminants can be discharged with air or vapour. Access to the fully programmable controller is via Astell’s PIN protected, full colour touch screen which displays cycle information and has facilities for data archiving and ethernet monitoring.
Astell offers full project assistance including an initial site survey to ascertain the volume of waste and advise the best treatment method, detailed engineering proposals, manufacture, delivery and installation of the equipment and IQ and OQ validation packages.
You may also like
Trending Articles
You may also like
Manufacturing
Domino demonstrates an integrated approach to next-generation coding at Interpack 2026
At Interpack 2026, Domino Printing Sciences (Domino) will focus on the key challenges manufacturers face as variable data printing enters a new era shaped by 2D codes, intelligent automation, sustainability, and growing traceability demands. Domino specialists will be available throughout the show to highlight integrated solutions designed to work together on the factory floor – developed in collaboration with key industry partners to help to reduce complexity, risk, and operational friction for manufacturers
Manufacturing
Bristol Myers Squibb licenses Lonza ADC linker-payload technology for undisclosed target
BMS has secured exclusive access to Lonza’s SYNtecan linker-payload platform, alongside GlycoConnect and HydraSpace technologies, to advance development of an antibody-drug conjugate against an undisclosed target
Manufacturing
Former Catalent Chair and CEO George Fotiades joins eXmoor Pharma board as Chair
Angela Osborne steps back from operational duties and continues as Founder and Board Director, providing strategic continuity as eXmoor builds the leadership depth to support its expanding integrated CDMO model